Neogen Corporation (NASDAQ:NEOG) Given Consensus Rating of “Hold” by Brokerages

by · The Cerbat Gem

Shares of Neogen Corporation (NASDAQ:NEOG – Get Free Report) have been assigned a consensus rating of “Hold” from the six brokerages that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $9.50.

NEOG has been the subject of several research reports. Piper Sandler set a $6.50 price target on shares of Neogen and gave the company a “neutral” rating in a research report on Thursday, October 16th. Wall Street Zen cut shares of Neogen from a “buy” rating to a “hold” rating in a report on Saturday. CJS Securities raised shares of Neogen from a “market perform” rating to an “outperform” rating and set a $10.00 target price for the company in a research report on Wednesday, December 10th. Guggenheim reaffirmed a “buy” rating and issued a $12.00 price target (up previously from $8.00) on shares of Neogen in a research report on Friday. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Neogen in a report on Monday, December 29th.

Get Our Latest Analysis on NEOG

More Neogen News

Here are the key news stories impacting Neogen this week:

  • Positive Sentiment: Q2 results beat consensus on key metrics and management raised FY2026 revenue guidance to $845–$855M (above consensus), signaling progress on a turnaround; investors liked the combination of revenue outperformance and guidance lift. Neogen Raises Guidance as Cost-Cutting Takes Hold
  • Positive Sentiment: Market reaction: the stock spiked sharply (reports note moves >30%) after the earnings and guidance, reflecting renewed investor optimism about revenue growth and cost actions. Why Neogen Stock Blasted More Than 31% Higher Today
  • Positive Sentiment: Heavy bullish options activity and call buying accompanied the move (unusually large call volume), suggesting speculative and institutional interest in the near-term upside. Neogen Posts Strong Q2 Earnings
  • Neutral Sentiment: Analyst & institutional context: a small number of upgrades and divergent price targets mean consensus is still forming; some funds have been reallocating positions into/out of NEOG. Q2 2026 Earnings Call Transcript
  • Negative Sentiment: Underlying GAAP metrics remain mixed: some reports show the company recorded operating and net losses and weaker operating cash flow in the quarter (contrast between adjusted EPS and GAAP results creates ambiguity about sustainable profitability). That tempers the bullish narrative and raises execution risk. QuiverQuant Q2 Earnings Summary

Neogen Stock Performance

Shares of Neogen stock opened at $9.62 on Wednesday. The business has a 50-day simple moving average of $6.66 and a 200 day simple moving average of $5.90. Neogen has a one year low of $3.87 and a one year high of $12.98. The company has a debt-to-equity ratio of 0.38, a current ratio of 3.91 and a quick ratio of 2.80. The firm has a market capitalization of $2.09 billion, a price-to-earnings ratio of -3.47 and a beta of 1.96.

Neogen (NASDAQ:NEOG – Get Free Report) last announced its quarterly earnings data on Thursday, January 8th. The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.07 by $0.03. The firm had revenue of $224.69 million during the quarter, compared to analysts’ expectations of $208.50 million. Neogen had a positive return on equity of 2.14% and a negative net margin of 68.47%.The company’s revenue for the quarter was down 2.9% compared to the same quarter last year. During the same quarter last year, the firm posted $0.11 earnings per share. On average, research analysts anticipate that Neogen will post 0.38 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Neogen

Several large investors have recently bought and sold shares of NEOG. Savant Capital LLC purchased a new position in Neogen during the 2nd quarter worth $50,000. Cresset Asset Management LLC bought a new position in shares of Neogen during the second quarter valued at about $53,000. Evergreen Capital Management LLC purchased a new position in Neogen during the second quarter worth about $56,000. Blue Trust Inc. grew its position in Neogen by 181.7% in the 2nd quarter. Blue Trust Inc. now owns 11,974 shares of the company’s stock worth $57,000 after purchasing an additional 7,724 shares in the last quarter. Finally, Osaic Holdings Inc. increased its stake in Neogen by 183.5% in the 2nd quarter. Osaic Holdings Inc. now owns 12,663 shares of the company’s stock valued at $61,000 after buying an additional 8,196 shares during the last quarter. 96.73% of the stock is currently owned by institutional investors.

Neogen Company Profile

(Get Free Report)

Neogen Corporation is a global provider of food and animal safety products, offering a broad portfolio of diagnostic and testing solutions. Headquartered in Lansing, Michigan, the company develops and manufactures tests designed to detect foodborne pathogens, allergens and toxins in food, beverage and environmental samples. Since its founding in 1982, Neogen has focused on delivering rapid, accurate and user‐friendly assays to food processors, grain handlers and quality laboratories around the world.

In the food safety arena, Neogen’s product lineup includes immunoassay kits, molecular diagnostics and enrichment media for pathogens such as Salmonella, Listeria and E.

Featured Stories